Feasibility Assessment of the Wellumio 'Axana' 0.1T Portable MRI Device

NCT07751328 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
60
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Wellumio R&D Australia Pty Ltd